Evaluation of Factors That Initiate Or Propagate Epidemic Coxiellosis in the U.S

Total Page:16

File Type:pdf, Size:1020Kb

Evaluation of Factors That Initiate Or Propagate Epidemic Coxiellosis in the U.S United States Department of Evaluation of Factors that Would Agriculture Animal and Initiate or Propagate Epidemic Plant Health Inspection Service Coxiellosis in the U.S. Veterinary Services Centers for Domesticated Goat Population Epidemiology and Animal Health June 2013 Suggested bibliographical citation for this report: USDA. (2012). Evaluation of factors that would initiate or propagate epidemic coxiellosis in the U.S. domesticated goat population. USDA:APHIS:VS:Centers for Epidemiology and Animal Health. Fort Collins, CO. June 2013. 104 pages. Abstract Coxiellosis is a zoonosis caused by Coxiella burnetii, an intracellular Gram-negative bacterium that is prevalent globally. Many animal species are susceptible to infection by C. burnetii, including ruminants, domestic carnivores, wildlife mammals, birds, and arthropods. The clinical presentation of coxiellosis is non- specific in most animals, with the exception of ruminants where coxiellosis is responsible for reduced fertility, abortions, and stillbirths during late gestation, as well as low birth weight. In humans, two clinical patterns of Q fever are observed. The acute disease resembles a flu-like syndrome, and is usually a self-limiting febrile illness during which pneumonia or hepatitis can occur. The chronic disease is a severe and possibly fatal illness. Q fever can lead to abortions, stillbirth, or premature deliveries in pregnant women. In fewer than 5 percent of the cases it causes chronic illness which includes endocarditis and chronic fatigue syndrome. In 2005, coxiellosis was diagnosed for the first time in ruminants in the Netherlands as a cause of abortion on a dairy goat farm. In 2006, 2007, 2008, and 2009, six, seven, seven, and six new cases, respectively, were confirmed on other dairy goat farms. During the same period, two cases of abortion caused by C. burnetii were found on dairy sheep farms. In 1978, human Q fever became a notifiable disease in the Netherlands. The number of notifications per year between 1978 and 2006 was one to 32. In 2007, 168 confirmed human cases were reported. In 2008, 1,000 human cases were reported, making this the largest community outbreak of Q fever ever recorded. In 2009, 2,357 human cases of Q fever were reported. The human Q fever cases were linked to abortion epidemics on large dairy goat farms and dairy sheep farms. In the United States, on April 22, 2011 the coxiellosis bacterium C. burnetii was detected in a goat placenta collected from a farm in Washington where does had aborted during January to April 2011. An epidemiological investigation concluded that goats from the index premises had been dispersed to 21 farms in 3 States. Seventeen farms participated in the outbreak investigation; C. burnetii infection was detected in 16 of 17 goat herds and in 161 of 667 (24 percent) goats tested. Q fever in at least six people was linked to the index farm and/or associated premises. Coxiella burnetii infection in domesticated goats in the United States is endemic, and outbreaks of coxiellosis in goats are sporadic. Continual expansion of the goat industry in the United States, along with the explosive and concurrent epidemic of Q fever in the European Union (EU) Member States, has increased concerns among animal and human health officials of the likelihood of a similar epidemic in goats in the United States. To alleviate the concerns, we identified and evaluated factors that could potentially initiate and/or propagate an epidemic of coxiellosis in the U.S. goat population. We concluded the likelihood is low that three factors would initiate and/or propagate an epidemic of coxiellosis in the domesticated goat population in the United States. These three factors are: (1) goat industry structure, (2) laboratory capacity to diagnose coxiellosis, and (3) reporting and monitoring coxiellosis. We concluded that the likelihood is medium that four additional factors would initiate and/or propagate an epidemic of coxiellosis. These four factors are: (1) goat health and general management, (2) accessibility to caprine health professionals, (3) responses to coxiellosis diagnosis, and (4) accessibility to coxiellosis vaccines. Finally, we concluded that the likelihood is low to medium that all seven factors, when considered together, would initiate and/or propagate an epidemic of coxiellosis in the U.S. domesticated goat population. Keywords: Q fever, Coxiella burnetii, coxiellosis, epidemic, goat disease Audience: Health professionals whose primary responsibilities are to develop risk-reduction strategies for transmissible infectious diseases of animals and humans. Inquiries to: Reginald Johnson, USDA:APHIS:VS:CEAH, 970-494-7326, 2150B Centre Avenue, Fort Collins, CO 80526. [email protected]. Evaluation of Factors that Would Initiate or Propagate Epidemic Coxiellosis in the U.S. Domesticated Goat Population Acknowledgements American Association of Small Ruminant Dr. Katherine L. Marshall, Analytical Practitioners Epidemiologist, Project Consultant, Area Epidemiology Officers, USDA:APHIS:VS USDA:APHIS:VS:CEAH:NAHMS Dr. Stanley D. Bruntz, NAHLN, Member-laboratories of the National USDA:APHIS:VS:CEAH Animal Health Laboratory Network Ms. Mary Foley, Librarian, State Veterinarians and Animal Health USDA:APHIS:VS:CEAH:CAHIA Agencies, United States Ms. Christine Kopral, Statistician, State Public Health Veterinarians and Public USDA:APHIS:VS:CEAH:NAHMS Health Agencies, United States Ms. Carmen D. Ledesma-Feliciano, VA-MD Dr. Sarah Tomlinson, Associate Coordinator, Regional College Veterinary Medicine, DVM National Animal Health Laboratory Network 2012 Ms. Julie E. Wallin, USDA:APHIS:VS:CEAH: Ms. Carol LoSapio, Technical Writer/Editor, National Surveillance Unit USDA:APHIS:VS:CEAH:CAHIA Contributors Mr. Andrew M. Fox, Cartographer, Dr. Reginald Johnson, Risk Analyst, USDA:APHIS:VS:CEAH:CAHIA USDA:APHIS:VS:CEAH:CAHIA Dr. Robert E. Harris, Veterinary Medical Dr. Philip D. Riggs, Technical Information Officer, USDA:APHIS:VS:CEAH:CAHIA Specialist, USDA:APHIS:VS:CEAH:CAHIA Scientific Reviewers Dr. Michelle P. Emery, Veterinary Medical Dr. Katherine L. Marshall, Caprine Commodity Officer, National Veterinary Services Specialist, One Health Coordinating Office Laboratories Dr. Kristyn L. Stone, Agricultural Economist, Dr. Alan Huddleston, Veterinary Medical USDA:APHIS:VS:CEAH:CAHIA Officer, National Center for Animal Health Dr. Diane L. Sutton, National Scrapie Program Programs Coordinator, National Center for Animal Health Programs The U.S. Department of Agriculture (USDA) prohibits mentioned. USDA neither guarantees nor warrants discrimination in all its programs and activities on the the standard of any product mentioned. Product basis of race, color, national origin, age, disability, names are mentioned solely to report factually on and where applicable, sex, marital status, familial available data and to provide specific information. status, parental status, religion, sexual orientation, genetic information, political beliefs, reprisal, or USDA–APHIS–VS–CEAH because all or part of an individual's income is derived NRRC Building B, M.S. 2W4 from any public assistance program. (Not all 2150 Centre Avenue prohibited bases apply to all programs.) Persons with Fort Collins, CO 80526-8117 disabilities who require alternative means for (970) 494–7000 communication of program information (Braille, large Email: [email protected] print, audiotape, etc.) should contact USDA's http://www.aphis.usda.gov/about_aphis/programs_ TARGET Center at (202) 720-2600 (voice and TDD). offices/veterinary_services/ceah.shtml To file a complaint of discrimination, write USDA, #210.0613 Director, Office of Civil Rights, 1400 Independence Avenue, SW, Washington, DC 20250-9410 or call (800) 795-3272 or (202) 720-6382 (TDD). USDA is an equal opportunity provider and employer. Cover photos courtesy of: top left, Reginald Johnson, Veterinarian Epidemiologist, USDA:APHIS:VS:Center for Epidemiology and Animal Mention of companies or commercial products does Health, Fort Collins, CO; bottom right, Christianne not imply recommendation or endorsement by the Bruschke, Chief Veterinary Officer, Ministry of U.S. Department of Agriculture over others not Agriculture, Nature, and Food Quality, Netherlands. Evaluation of Factors that Initiate or Propagate Epidemic Coxiellosis in the U.S. Domesticated Goat Population Contents Acronyms ........................................................................................................................................ vi Glossary .......................................................................................................................................... vi 1. Executive Summary ........................................................................................................... 1 2. Introduction and Background ........................................................................................... 5 2.1 Coxiellosis and Q fever in the Netherlands, 2005 to 2010 ........................................................ 5 2.2 Coxiellosis and Q fever Outbreak Associated with Goats ........................................................ 5 2.3 Summary ................................................................................................................................... 6 2.4 Bibliography ............................................................................................................................... 7 3. Hazard Identification of Coxiellosis and Q fever .............................................................
Recommended publications
  • Distribution of Tick-Borne Diseases in China Xian-Bo Wu1, Ren-Hua Na2, Shan-Shan Wei2, Jin-Song Zhu3 and Hong-Juan Peng2*
    Wu et al. Parasites & Vectors 2013, 6:119 http://www.parasitesandvectors.com/content/6/1/119 REVIEW Open Access Distribution of tick-borne diseases in China Xian-Bo Wu1, Ren-Hua Na2, Shan-Shan Wei2, Jin-Song Zhu3 and Hong-Juan Peng2* Abstract As an important contributor to vector-borne diseases in China, in recent years, tick-borne diseases have attracted much attention because of their increasing incidence and consequent significant harm to livestock and human health. The most commonly observed human tick-borne diseases in China include Lyme borreliosis (known as Lyme disease in China), tick-borne encephalitis (known as Forest encephalitis in China), Crimean-Congo hemorrhagic fever (known as Xinjiang hemorrhagic fever in China), Q-fever, tularemia and North-Asia tick-borne spotted fever. In recent years, some emerging tick-borne diseases, such as human monocytic ehrlichiosis, human granulocytic anaplasmosis, and a novel bunyavirus infection, have been reported frequently in China. Other tick-borne diseases that are not as frequently reported in China include Colorado fever, oriental spotted fever and piroplasmosis. Detailed information regarding the history, characteristics, and current epidemic status of these human tick-borne diseases in China will be reviewed in this paper. It is clear that greater efforts in government management and research are required for the prevention, control, diagnosis, and treatment of tick-borne diseases, as well as for the control of ticks, in order to decrease the tick-borne disease burden in China. Keywords: Ticks, Tick-borne diseases, Epidemic, China Review (Table 1) [2,4]. Continuous reports of emerging tick-borne Ticks can carry and transmit viruses, bacteria, rickettsia, disease cases in Shandong, Henan, Hebei, Anhui, and spirochetes, protozoans, Chlamydia, Mycoplasma,Bartonia other provinces demonstrate the rise of these diseases bodies, and nematodes [1,2].
    [Show full text]
  • Q Fever in Small Ruminants and Its Public Health Importance
    Journal of Dairy & Veterinary Sciences ISSN: 2573-2196 Review Article Dairy and Vet Sci J Volume 9 Issue 1 - January 2019 Copyright © All rights are reserved by Tolera Tagesu Tucho DOI: 10.19080/JDVS.2019.09.555752 Q Fever in Small Ruminants and its Public Health Importance Tolera Tagesu* School of Veterinary Medicine, Jimma University, Ethiopia Submission: December 01, 2018; Published: January 11, 2019 *Corresponding author: Tolera Tagesu Tucho, School of Veterinary Medicine, Jimma University, Jimma Oromia, Ethiopia Abstract Query fever is caused by Coxiella burnetii, it’s a worldwide zoonotic infectious disease where domestic small ruminants are the main reservoirs for human infections. Coxiella burnetii, is a Gram-negative obligate intracellular bacterium, adapted to thrive within the phagolysosome of the phagocyte. Humans become infected primarily by inhaling aerosols that are contaminated with C. burnetii. Ingestion (particularly drinking raw milk) and person-to-person transmission are minor routes. Animals shed the bacterium in urine and feces, and in very high concentrations in birth by-products. The bacterium persists in the environment in a resistant spore-like form which may become airborne and transported long distances by the wind. It is considered primarily as occupational disease of workers in close contact with farm animals or processing their be commenced immediately whenever Q fever is suspected. To prevent both the introduction and spread of Q fever infection, preventive measures shouldproducts, be however,implemented it may including occur also immunization in persons without with currently direct contact. available Doxycycline vaccines drugof domestic is the first small line ruminant of treatment animals for Q and fever.
    [Show full text]
  • Coxiella Burnetii
    SENTINEL LEVEL CLINICAL LABORATORY GUIDELINES FOR SUSPECTED AGENTS OF BIOTERRORISM AND EMERGING INFECTIOUS DISEASES Coxiella burnetii American Society for Microbiology (ASM) Revised March 2016 For latest revision, see web site below: https://www.asm.org/Articles/Policy/Laboratory-Response-Network-LRN-Sentinel-Level-C ASM Subject Matter Expert: David Welch, Ph.D. Medical Microbiology Consulting Dallas, TX [email protected] ASM Sentinel Laboratory Protocol Working Group APHL Advisory Committee Vickie Baselski, Ph.D. Barbara Robinson-Dunn, Ph.D. Patricia Blevins, MPH University of Tennessee at Department of Clinical San Antonio Metro Health Memphis Pathology District Laboratory Memphis, TN Beaumont Health System [email protected] [email protected] Royal Oak, MI BRobinson- Erin Bowles David Craft, Ph.D. [email protected] Wisconsin State Laboratory of Penn State Milton S. Hershey Hygiene Medical Center Michael A. Saubolle, Ph.D. [email protected] Hershey, PA Banner Health System [email protected] Phoenix, AZ Christopher Chadwick, MS [email protected] Association of Public Health Peter H. Gilligan, Ph.D. m Laboratories University of North Carolina [email protected] Hospitals/ Susan L. Shiflett Clinical Microbiology and Michigan Department of Mary DeMartino, BS, Immunology Labs Community Health MT(ASCP)SM Chapel Hill, NC Lansing, MI State Hygienic Laboratory at the [email protected] [email protected] University of Iowa [email protected] Larry Gray, Ph.D. Alice Weissfeld, Ph.D. TriHealth Laboratories and Microbiology Specialists Inc. Harvey Holmes, PhD University of Cincinnati College Houston, TX Centers for Disease Control and of Medicine [email protected] Prevention Cincinnati, OH om [email protected] [email protected] David Welch, Ph.D.
    [Show full text]
  • Bartonella Henselae and Coxiella Burnetii Infection and the Kawasaki Disease
    GALLEY PROOF J. Appl. Sci. Environ. Mgt. 2004 JASEM ISSN 1119-8362 Available Online at All rights reserved http:// www.bioline.org.br/ja Vol. 8 (1) 11 - 12 Bartonella henselae and Coxiella burnetii Infection and the Kawasaki Disease KEI NUMAZAKI, M D Department of Pediatrics, Sapporo Medical University School of Medicine, S.1 W.16 Chuo-ku Sapporo, 060-8543 Japan Phone: +81-611-2111 X3413 Fax: +81-611-0352 E-mail: [email protected] ABSTRACT: It was reported that Bartonella henselae, B. quintana and Coxiella burnetii was not strongly associated with coronary artery disease but on the basis of geometric mean titer, C. burnetii infection might have a modest association with coronary artery disease. Serum antibodies to B. henselae from 14 patients with acute phase of Kawasaki disease were determined by the indirect fluorescence antibody assay . Serum antibodies to C. burnetii were also tried to detect. However, no positive results were obtained. I also examined 10 children and 10 pregnant women who had serum IgG antibody to B. henselae or to C. burnetii. No one showed abnormal findings of coronary artery. @JASEM Several Bartonella species cause illness and associated with several infections, including asymptotic infection in humans. B. henselae has Chlamydia pneumoniae, cytomegalovirus, been associated with an increasing spectrum of Helicobacter pylori and other intercellular bacteria clinical syndromes including cat scratch disease. (Danesh et al., 1997). Previous studies supported Although the clinical spectrum has not been the possibility of certain populations having an completely clarified, B. quintana may cause association of infections and coronary artery disease blood-culture negative endocarditis in children Kawasaki disease (KD).
    [Show full text]
  • Coxiella Burnetii, the Agent of Q Fever in Brazil
    Mem Inst Oswaldo Cruz, Rio de Janeiro, Vol. 107(5): 695-697, August 2012 695 Coxiella burnetii, the agent of Q fever in Brazil: its hidden role in seronegative arthritis and the importance of molecular diagnosis based on the repetitive element IS1111 associated with the transposase gene Tatiana Rozental1/+, Luis Filipe Mascarenhas2, Ronaldo Rozenbaum2,3, Raphael Gomes1, Grasiely Souza Mattos1, Cecília Carlos Magno4, Daniele Nunes Almeida1, Maria Inês Doria Rossi1, Alexsandra RM Favacho1, Elba Regina Sampaio de Lemos1 1Laboratório de Hantaviroses e Rickettsioses, Instituto Oswaldo Cruz-Fiocruz, Rio de Janeiro, RJ, Brasil 2Hospital Servidores do Estado, Rio de Janeiro, RJ, Brasil 3Hospital Samaritano, Rio de Janeiro, RJ, Brasil 4Hospital Copa-D’Or, Rio de Janeiro, RJ, Brasil Coxiella burnetii is the agent of Q fever, an emergent worldwide zoonosis of wide clinical spectrum. Although C. burnetii infection is typically associated with acute infection, atypical pneumonia and flu-like symptoms, endo- carditis, osteoarticular manifestations and severe disease are possible, especially when the patient has a suppressed immune system; however, these severe complications are typically neglected. This study reports the sequencing of the repetitive element IS1111 of the transposase gene of C. burnetii from blood and bronchoalveolar lavage (BAL) samples from a patient with severe pneumonia following methotrexate therapy, resulting in the molecular diagnosis of Q fever in a patient who had been diagnosed with active seronegative polyarthritis two years earlier. To the best of our knowledge, this represents the first documented case of the isolation of C. burnetii DNA from a BAL sample. Key words: Q fever - bronchoalveolar lavage - molecular analysis - seronegative polyarthritis - methotrexate Q fever is caused by Coxiella burnetii, a small obli- patients present symptoms of Q fever fatigue syndrome gate intracellular Gram-negative bacterium of the order (QFS), characterised by headache, joint and muscle pain Legionellales (Stein et al.
    [Show full text]
  • Tick-Borne Disease Working Group 2020 Report to Congress
    2nd Report Supported by the U.S. Department of Health and Human Services • Office of the Assistant Secretary for Health Tick-Borne Disease Working Group 2020 Report to Congress Information and opinions in this report do not necessarily reflect the opinions of each member of the Working Group, the U.S. Department of Health and Human Services, or any other component of the Federal government. Table of Contents Executive Summary . .1 Chapter 4: Clinical Manifestations, Appendices . 114 Diagnosis, and Diagnostics . 28 Chapter 1: Background . 4 Appendix A. Tick-Borne Disease Congressional Action ................. 8 Chapter 5: Causes, Pathogenesis, Working Group .....................114 and Pathophysiology . 44 The Tick-Borne Disease Working Group . 8 Appendix B. Tick-Borne Disease Working Chapter 6: Treatment . 51 Group Subcommittees ...............117 Second Report: Focus and Structure . 8 Chapter 7: Clinician and Public Appendix C. Acronyms and Abbreviations 126 Chapter 2: Methods of the Education, Patient Access Working Group . .10 to Care . 59 Appendix D. 21st Century Cures Act ...128 Topic Development Briefs ............ 10 Chapter 8: Epidemiology and Appendix E. Working Group Charter. .131 Surveillance . 84 Subcommittees ..................... 10 Chapter 9: Federal Inventory . 93 Appendix F. Federal Inventory Survey . 136 Federal Inventory ....................11 Chapter 10: Public Input . 98 Appendix G. References .............149 Minority Responses ................. 13 Chapter 11: Looking Forward . .103 Chapter 3: Tick Biology, Conclusion . 112 Ecology, and Control . .14 Contributions U.S. Department of Health and Human Services James J. Berger, MS, MT(ASCP), SBB B. Kaye Hayes, MPA Working Group Members David Hughes Walker, MD (Co-Chair) Adalbeto Pérez de León, DVM, MS, PhD Leigh Ann Soltysiak, MS (Co-Chair) Kevin R.
    [Show full text]
  • The Clinical Neuropsychiatry of Stroke, Second Edition
    The Clinical Neuropsychiatry of Stroke This fully revised new edition covers the range of neuropsychiatric syndromes associated with stroke, including cognitive, emotional, and behavioral disorders such as depression, anxiety, and psychosis. Since the last edition there has been an explosion of published literature on this topic and the book provides a comprehensive, systematic, and cohesive review of this new material. There is growing recognition among a wide range of clinicians and allied healthcare staff that poststroke neuropsychiatric syndromes are both common and serious. Such complications can have a negative impact on recovery and even survival; however, there is now evidence suggesting that pre-emptive therapeutic intervention in high-risk patient groups can prevent the initial onset of the conditions. This opportunity for primary prevention marks a huge advance in the man- agement of this patient population. This book should be read by all those involved in the care of stroke patients, including psychiatrists, neurologists, rehabilitation specialists, and nurses. Robert Robinson is a Paul W. Penningroth Professor and Head, Department of Psychiatry; Roy J. and Lucille A., Carver College of Medicine, The University of Iowa, IA, USA. The Clinical Neuropsychiatry of Stroke Second Edition Robert G. Robinson cambridge university press Cambridge, New York, Melbourne, Madrid, Cape Town, Singapore, São Paulo Cambridge University Press The Edinburgh Building, Cambridge cb2 2ru,UK Published in the United States of America by Cambridge University Press, New York www.cambridge.org Informationonthistitle:www.cambridge.org/9780521840071 © R. Robinson 2006 This publication is in copyright. Subject to statutory exception and to the provision of relevant collective licensing agreements, no reproduction of any part may take place without the written permission of Cambridge University Press.
    [Show full text]
  • Environmental Nutrition: Redefining Healthy Food
    Environmental Nutrition Redefining Healthy Food in the Health Care Sector ABSTRACT Healthy food cannot be defined by nutritional quality alone. It is the end result of a food system that conserves and renews natural resources, advances social justice and animal welfare, builds community wealth, and fulfills the food and nutrition needs of all eaters now and into the future. This paper presents scientific data supporting this environmental nutrition approach, which expands the definition of healthy food beyond measurable food components such as calories, vitamins, and fats, to include the public health impacts of social, economic, and environmental factors related to the entire food system. Adopting this broader understanding of what is needed to make healthy food shifts our focus from personal responsibility for eating a healthy diet to our collective social responsibility for creating a healthy, sustainable food system. We examine two important nutrition issues, obesity and meat consumption, to illustrate why the production of food is equally as important to consider in conversations about nutrition as the consumption of food. The health care sector has the opportunity to harness its expertise and purchasing power to put an environmental nutrition approach into action and to make food a fundamental part of prevention-based health care. but that it must come from a food system that conserves and I. Using an Environmental renews natural resources, advances social justice and animal welfare, builds community wealth, and fulfills the food and Nutrition Approach to nutrition needs of all eaters now and into the future.i Define Healthy Food This definition of healthy food can be understood as an environmental nutrition approach.
    [Show full text]
  • Managing Communicable Diseases in Child Care Settings
    MANAGING COMMUNICABLE DISEASES IN CHILD CARE SETTINGS Prepared jointly by: Child Care Licensing Division Michigan Department of Licensing and Regulatory Affairs and Divisions of Communicable Disease & Immunization Michigan Department of Health and Human Services Ways to Keep Children and Adults Healthy It is very common for children and adults to become ill in a child care setting. There are a number of steps child care providers and staff can take to prevent or reduce the incidents of illness among children and adults in the child care setting. You can also refer to the publication Let’s Keep It Healthy – Policies and Procedures for a Safe and Healthy Environment. Hand Washing Hand washing is one of the most effective way to prevent the spread of illness. Hands should be washed frequently including after diapering, toileting, caring for an ill child, and coming into contact with bodily fluids (such as nose wiping), before feeding, eating and handling food, and at any time hands are soiled. Note: The use of disposable gloves during diapering does not eliminate the need for hand washing. The use of gloves is not required during diapering. However, if gloves are used, caregivers must still wash their hands after each diaper change. Instructions for effective hand washing are: 1. Wet hands under warm, running water. 2. Apply liquid soap. Antibacterial soap is not recommended. 3. Vigorously rub hands together for at least 20 seconds to lather all surfaces of the hands. Pay special attention to cleaning under fingernails and thumbs. 4. Thoroughly rinse hands under warm, running water. 5.
    [Show full text]
  • Regulations for Disease Reporting and Control
    Department of Health Regulations for Disease Reporting and Control Commonwealth of Virginia State Board of Health October 2016 Virginia Department of Health Office of Epidemiology 109 Governor Street P.O. Box 2448 Richmond, VA 23218 Department of Health Department of Health TABLE OF CONTENTS Part I. DEFINITIONS ......................................................................................................................... 1 12 VAC 5-90-10. Definitions ............................................................................................. 1 Part II. GENERAL INFORMATION ............................................................................................... 8 12 VAC 5-90-20. Authority ............................................................................................... 8 12 VAC 5-90-30. Purpose .................................................................................................. 8 12 VAC 5-90-40. Administration ....................................................................................... 8 12 VAC 5-90-70. Powers and Procedures of Chapter Not Exclusive ................................ 9 Part III. REPORTING OF DISEASE ............................................................................................. 10 12 VAC 5-90-80. Reportable Disease List ....................................................................... 10 A. Reportable disease list ......................................................................................... 10 B. Conditions reportable by directors of
    [Show full text]
  • Farm Schools in Canada and Australia
    i No. M-118 Copy No. of STUDIES OF MIGRATION AND SETTLEMENT Memorandum Series I', J! Subject: Fairbridge Farm Schools in Canada and Australia \ Date: July 13, 1944 t: I Study Room 115 Library of Congress Annex Washington, D. c. Tel . Republic 5127 July 13, 1944 FAIRBRIDGE FARM SCHOOLS IN CANADA The attached Report on the Fairbridge Farm ' Schools, which were founded at Oxford University in 1909 by Kingsley Fairbridge, has been selected by the Staff of 11 M11 Project for inclusion in our Series. co E I Boys entrusted with the real job at Northcote Children's Farm, Bacchus Marsh, Victoria, Australia. FAIRBRIDGE FARM SCHOOLS Thirty-first Year · Fairbridge children who enjoyed the bounteous hospitality of the Canadian Pacific M erchant S eamen on the voyage to Australia in S eptember, 1940. To all friends of Fairbridge If it had been possible to hold the usual Annual General Meeting, when hundreds of our subscribers and friends assemble, we should have asked Major-General Victor Odlum to speak to you. He has, however, very kindly written his message and we are happy to print it. But before I give . you his words, I must set down here some remarks on our work, its present state and its prospects. CHA R LES HAM B RO, Chairman. " Dining in Hall" at the Babies' Home. T is with very great regret that this year we some new friends. We have further been sustained cannot issue the Annual Report in its usual by the signing of Deeds of Covenant by an in­ Iform. The customary edition requires much creasing number of our regular subscribers.
    [Show full text]
  • ICD-10 International Statistical Classification of Diseases and Related Health Problems
    ICD-10 International Statistical Classification of Diseases and Related Health Problems 10th Revision Volume 2 Instruction manual 2010 Edition WHO Library Cataloguing-in-Publication Data International statistical classification of diseases and related health problems. - 10th revision, edition 2010. 3 v. Contents: v. 1. Tabular list – v. 2. Instruction manual – v. 3. Alphabetical index. 1.Diseases - classification. 2.Classification. 3.Manuals. I.World Health Organization. II.ICD-10. ISBN 978 92 4 154834 2 (NLM classification: WB 15) © World Health Organization 2011 All rights reserved. Publications of the World Health Organization are available on the WHO web site (www.who.int) or can be purchased from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel.: +41 22 791 3264; fax: +41 22 791 4857; e-mail: [email protected]). Requests for permission to reproduce or translate WHO publications – whether for sale or for noncommercial distribution – should be addressed to WHO Press through the WHO web site (http://www.who.int/about/licensing/copyright_form). The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned.
    [Show full text]